603976.SHG ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
- Market cap
- CNY 5.34B
- P/E
- 207.3x
- P/B
- 3.15x
- ROE
- 1.5%
- Dividend yield
- 0.83%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 603976.SHG undervalued?
Graham numberThe Graham number of ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd fundamental analysis
No fundamental analysis for ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd yet.
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd engages in the research and development, manufacturing, and selling of pharmaceutical glass packaging materials in China and internationally. It offers neutral borosilicate glass ampoule and tube injection bottles, low borosilicate tubular vial and ampoule bottles, and screw neck vials. The company also provides aluminum caps, aluminum-plastic composite caps, and other medicinal caps. Its products are used in biological p…
Full company profileChongQing Zhengchuan Pharmaceutical Packaging Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 470M | 509M | 596M | 521M | 502M | 797M | 796M | 901M | 801M | 664M | 727M |
| Gross Profit | 147M | 161M | 171M | 141M | 107M | 198M | 153M | 142M | 147M | 121M | 123M |
| Operating Income | 79.3M | 96.7M | 94.1M | 71.9M | 61.9M | 123M | 58.8M | 44.9M | 65.3M | 48.1M | 53.5M |
| EBITDA | 115M | 139M | 142M | 123M | 115M | 205M | 164M | 172M | 196M | 148M | 46.5M |
| Net Income | 70.5M | 82.2M | 82.8M | 61.1M | 53.1M | 107M | 64.8M | 40.3M | 53.2M | 18.9M | 24.0M |
| EPS | 0.62 | 0.65 | 0.55 | 0.40 | 0.35 | 0.71 | 0.43 | 0.27 | 0.35 | 0.13 | 0.14 |
| Balance Sheet | |||||||||||
| Total Assets | 621M | 1.06B | 1.13B | 1.24B | 1.32B | 1.96B | 2.01B | 2.04B | 1.96B | 1.90B | 1.90B |
| Total Liabilities | 106M | 108M | 139M | 205M | 284M | 795M | 823M | 827M | 733M | 696M | 273M |
| Shareholders' Equity | 515M | 954M | 987M | 1.04B | 1.04B | 1.17B | 1.18B | 1.22B | 1.22B | 1.21B | 1.63B |
| Cash & Short-term Investments | 76.8M | 433M | 387M | 368M | 269M | 647M | 371M | 438M | 249M | 325M | 217M |
| Total Debt | 10.0M | 6.00M | 13.0M | 74.3M | 49.7M | 434M | 460M | 446M | 432M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 25.7M | 52.5M | 64.3M | 55.3M | 122M | 105M | 38.4M | 194M | 112M | 136M | - |
| Capital Expenditure | 8.88M | 40.5M | 69.2M | 112M | 176M | 138M | 276M | 90.0M | 72.0M | 27.1M | 73.8M |
| Free Cash Flow | 16.8M | 12.0M | -4.90M | -56.4M | -54.1M | -32.6M | -238M | 104M | 40.2M | 109M | 116M |
| Ratios | |||||||||||
| ROE | 13.7% | 8.6% | 8.4% | 5.9% | 5.1% | 9.1% | 5.5% | 3.3% | 4.4% | 1.6% | 1.5% |
| ROA | 11.4% | 7.7% | 7.3% | 4.9% | 4.0% | 5.4% | 3.2% | 2.0% | 2.7% | 1.0% | 1.3% |
| Net Profit Margin | 15.0% | 16.2% | 13.9% | 11.7% | 10.6% | 13.4% | 8.1% | 4.5% | 6.6% | 2.8% | 3.3% |
| Debt to Equity | 0.02x | 0.01x | 0.01x | 0.07x | 0.05x | 0.37x | 0.39x | 0.37x | 0.35x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd dividends
- Dividend yield
- 0.83%
- Forward dividend
- 0.29 CNY
- Payout ratio
- 235.3%
- Ex-dividend date
- May 28, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 44.5M | 0.29 | 235.3% |
| 2024 | CNY 50.7M | 0.33 | 95.2% |
| 2023 | CNY 13.3M | 0.09 | 33.1% |
| 2022 | CNY 49.6M | 0.33 | 76.7% |
| 2021 | CNY 6.20M | 0.04 | 5.8% |
| 2020 | CNY 48.6M | 0.32 | 91.7% |
| 2019 | CNY 12.1M | 0.08 | 19.8% |
| 2018 | CNY 49.7M | 0.33 | 60.0% |
| 2017 | CNY 4.08M | 0.03 | 5.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on May 28, 2018.
Who owns ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
- Insiders 62.98%
- Institutions 0.29%
- Public & others 36.73%
- Shares outstanding 172M
- Free float 56.1M
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd company profile
- Company name
- ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
- Ticker
- 603976.SHG
- ISIN
- CNE100002W50
- Exchange
- Shanghai Stock Exchange
- Sector
- Consumer Cyclical
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,361
- Fiscal year end
- December
- Address
- Zhengchuan Glass Industrial Park, Chongqing, China, 400700
- Phone
- 86 23 6834 9810
- Website
- cqzcjt.com
About ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd engages in the research and development, manufacturing, and selling of pharmaceutical glass packaging materials in China and internationally. It offers neutral borosilicate glass ampoule and tube injection bottles, low borosilicate tubular vial and ampoule bottles, and screw neck vials. The company also provides aluminum caps, aluminum-plastic composite caps, and other medicinal caps. Its products are used in biological preparations, traditional Chinese medicine preparations, and chemical medicines. The company was founded in 1988 and is headquartered in Chongqing, China.
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd management
4- Ms. Hanrong XiaoCFO & Accounting Supervisor · born 1970
- Mr. Qing XiaoDeputy GM & Director · born 1966
- Mr. Fengan JiangDeputy GM & Director · born 1970
- Mr. Shiping FeiSecretary of the Board of Directors · born 1978